Sponsored session - OncoCollective: Driving policy change to ensure equal access to transformative cancer innovations

As global health care systems face compounding social, economic and political pressure, our health care ecosystem must become more adaptive to ensure that people living with cancer can benefit from transformational innovations through timely access. To address this challenge and push forward adaptive ideas to support health system delivery, modernize policy frameworks and improve patient outcomes, Sanofi convened the OncoCollective – a multistakeholder group drawn from across the global oncology community – has focused on the biggest tension points in oncology and has developed new thinking and pathways toward implementable solutions.This panel discussion will share insights from this group of oncology experts - comprised of patient advocacy, clinical practice and value and access leaders - specifically their initial efforts to identify the barriers impeding equal access to optimal treatment associated with selected tumor types, based on an analysis of non-small cell lung cancer and relapsed/refractory multiple myeloma. OncoCollective seeks to engage the wider cancer community with its findings and welcomes discussion around fresh insights - following their convening at ESMO 2024 - as they dive deeper into the challenge of building acceptance for surrogate endpoints across key decision makers in order to increase the speed that innovation reaches people living with cancer.